Skip to main content

Table 3 Persistence patterns of top five prescribing anti-epileptic drugs as monotherapy

From: Analysis of treatment adherence and cost among patients with epilepsy: a four‐year retrospective cohort study in Pakistan

 

Continuers

N (%)

Switchers

N (%)

Discontinuers

N (%)

Levetiracetam**

2042 (54.1)

514 (13.5)

1224 (32.4)

Valproic acid**

1158 (47.8)

814 (33.5)

452 (18.7)

Carbamazepine*

745 (46.3)

299 (18.6)

564 (35.1)

Lamotrigine**

780 (60.6)

203 (15.7)

305 (23.7)

Lacosamide*

614 (57.5)

144 (13.5)

310 (29.0)

Others*

299 (22.6)

280 (21.2)

743 (56.2)

Total*

5638 (49.0)

2254 (19.7)

3598 (31.3)

  1. Phenobarbital, phenytoin, gabapentin, pregabalin and oxcarbazepine were categorized as others AEDs
  2. Total (11,490 N) Patients
  3. *P < 0.05; **P < 0.005